Home›Search›Revisiones en Cancer

Revisiones en Cancer

ARAN Ediciones S.A. · Spain

ISSN0213-8573

SJR Q4✓ Scopus / SJR

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q446

Total46

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Bottom 25%

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

SJR Scorei

0.102

H-Indexi

SNIPi

0.003

Total Worksi

114

Total Citationsi

202

2yr Mean Citednessi

0.06

Open Impact Factor alternative

Aims & Scope

Subject areas: Oncology.

General Information

Country / RegionSpain

Primary Language—

1st Year Published—

Annual Volume~ 30 articles / year

StatusActive

Total Publications114

Submission Info

Publishing ModelSubscription

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/12 · 33%

✅

Do you know the journal / publisher?

ARAN Ediciones S.A.

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

0213-8573

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

194

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ4

Subject Classification

Scopus Categories

Oncology

Research Topics (OpenAlex)

Breast Cancer Treatment StudiesOvarian cancer diagnosis and treatmentHead and Neck Cancer StudiesProstate Cancer Treatment and ResearchHepatocellular Carcinoma Treatment and PrognosisLung Cancer Treatments and MutationsEndometrial and Cervical Cancer TreatmentsCancer Diagnosis and TreatmentAdvanced Breast Cancer TherapiesLung Cancer Diagnosis and Treatment

Frequently asked questions about Revisiones en Cancer

Is Revisiones en Cancer a predatory journal?

PubScope has no integrity flags on record for Revisiones en Cancer: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 46/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Revisiones en Cancer?

Revisiones en Cancer is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.102.

Is Revisiones en Cancer indexed in Scopus and Web of Science?

Revisiones en Cancer is indexed in Scopus.

What is the aims and scope of Revisiones en Cancer?